A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years
This study is enrolling participants by invitation only.
Kenyatta National Hospital
University of Washington
Merck Sharp & Dohme Corp.
Kenya Medical Research Institute
Information provided by (Responsible Party):
Nelly R. Mugo, Kenyatta National Hospital
First received: September 30, 2011
Last updated: October 27, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||December 2019|
|Estimated Primary Completion Date:||November 2018 (Final data collection date for primary outcome measure)|